Liver transplant showdown: which method works best for colon cancer patients?

NCT ID NCT06698146

First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This study looks at different ways to perform a liver transplant in people whose colorectal cancer has spread to the liver and cannot be removed by surgery. Researchers will compare living versus deceased donor transplants, whole versus split organs, and one-stage versus two-stage procedures. They will track survival, recovery, and complications over one year. The goal is to find out which method works best for these patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
liver transplant (living or deceased donor, whole or split organ, one-stage or two-stage procedure)
What this could lead to
If successful, this study could help identify the best liver transplant approach for people with colorectal cancer that has spread to the liver, potentially improving survival and recovery.
What could go wrong
This is an observational registry study, not a treatment trial, so it won't test a new therapy. Results may not apply to all patients, and liver transplant carries serious risks like rejection and infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLON CANCER LIVER METASTASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Northwestern University-Comprehensive Transplant Center

    RECRUITING

    Chicago, Illinois, 60611, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.